Tiens Biotech Group (USA), Inc. (Tiens USA), incorporated on July 13, 1990, researches, develops, manufactures, and markets nutrition supplement products, including wellness products and dietary supplement products. The Company's operations are conducted from its headquarters in Tianjin, People’s Republic of China through Tiens USA's 80% owned subsidiary, Tianjin Tianshi Biological Development C
Comentario del IBEX 35: cierra el IBEX en los 8.834 puntos al subir un 3,81%. El volumen, sin ser espectacular, al menos acompaña las ganancias del mercado, que ha vuelto a ser muy volátil en una jornada que se esperaba netamente bajista tras el descalabro de ayer lunes en USA. Pero... ¿a donde vamos? aun puede continuar el rebote, pero antes debe ratificar otras cosas. Mientras tanto no cabe
NEW YORK, Nov. 14 /Xinhua-PRNewswire-FirstCall/ -- Tiens Biotech Group(USA), Inc. (the "Company" or "Tiens", (NYSE Alternext US: TBV), , announced financial results for the third quarterand nine months ended September 30, 2008. For the third quarter ended September 30, 2008, revenue was $26.2 million,an increase of 137.6% compared to $11.0 million for the third quarter endedSeptember 30, 2007.Net
Biotechnology sector of India is not a new one. It has been nourished since its inception by national government. Nevertheless, this industry is still in the infant stage. Currently, India is investing in academics and existing industry's infrastructure considerably to expedite the overall growth of sector.Biopharma sector enjoys the major share of the total biotech market. It comprises of therape
Closely following information technology, the next success in India is biotechnology. As per Mckinsey by 2020, only two main biotechnology companies will comprise a market capitalization, which will be the same as the collective market capitalization of all of the IT companies at present.This rapid growth in biotechnology is working as an incentive to bio-industry executives, research scientists,
Amgen Inc. (NASDAQ: AMGN) has just posted earnings. The biotech giant for anemia treatments posted $1.09 GAAP EPS and adjusted earnings of $1.23 non-GAAP EPS...
[[ This is a content summary only. Visit my website for full links, other content, and more! ]]
Dynavax Technologies Corp. (NASDAQ: DVAX) is the latest biotech implosion as shares are down some 75% today. The company gave an update on an FDA clinical hold...
[[ This is a content summary only. Visit my website for full links, other content, and more! ]]
Chemcel Biotech a company engaged in the business of agro-chemicals closed at Rs 5.15 on the BSE against issue price of Rs 16 at a huge discount of 67.81%.
The scrip touched an intraday high of Rs...
[[ This is a content summary only. Visit my website for full links, other content, and more! ]]
A few months ago we saw the biotechs showing relative strength as can be seen by the rising ratio line from May going into June. What followed was an explosive rally in July. You'll notice in the above chart that the MACD triggered a buy signal in early July which turned out to be quite profitable. I believe we are seeing the same pattern take place right now.
In the above chart of XBI (
The global food crisis has many causes. However, according to the biotechnology industry, there’s a simple solution: genetically modified crops. Biotech multinationals have touted miracle crops that will supposedly increase yields, tolerate droughts, and grow in saline soils.
But not everyone is convinced. In fact, the UN and World Bank recently completed an broad scientific assessment of world
Incorporated in 1995, Chemcel Biotech Limited is in the business of manufacturing of Agro Chemicals. Company’s main products are in three forms i.e. liquids, granules and dusts. Chemcel Biotech has CIB registrations for 34 products to manufacture pesticides for crops i.e. Paddy, Cotton, Sugarcane, Turmeric, Chillies, Pulses, Vegetable etc.They have 34 products in their product portfolio which co
Incorporated in 1995, Chemcel Biotech Limited is in the business of manufacturing of Agro Chemicals. Company’s main products are in three forms i.e. liquids, granules and dusts. Chemcel Biotech has CIB registrations for 34 products to manufacture pesticides for crops i.e. Paddy, Cotton, Sugarcane, Turmeric, Chillies, Pulses, Vegetable etc.They have certificate of registrations for 34 formulation
The second largest city in the Czech Republic is hoping to capitalize on its skilled workforce and partnership with the United States Mayo Clinic by becoming a European biotechnology hub. The research center that is based in Rochester, Minnesota is known around the globe for treating rare diseases and some of the biggest names in the world, as well as performing research. It is the first tim
Hi ThereA good news for those who still counting on biotech ..There s a company shortly openin .. in the year ending.Company's name is disclosed due to marketing stratgies anyways.Requirement: A very sound pratical knoweldge in the field of biotech is a must.Qualification: post graduates..Experience >1 year .. (added advantage)(additonal diplomas or any related on job traning courses will be an ad
Name: pps Q: I m a b.sc bio tech student for my better career what i go with , wheater for the m.sc bio tech or MBA bio tech i which their will be a good scope.
By Dr. Steve SjuggerudIf you catch just one biotech bull market, you'll never have to work again.I've said that many times. The average biotech bull market has been good for 566% gains in less than three years.At the moment, biotech is looking incredibly bullish right now. Yesterday was the turning point...Yesterday, shares of biotech giant Genentech shot up 13% as big pharmaceutical company Roche
Capitalizing in the Biotech IndustryAction Biotech believes in the substantial future potential of stem cell treatments for many serious health conditions. They are venture capitalists who invest strategically in small companies that have promising stem cell capabilities.Some of the Californian stem cell companies in which they have invested are beginning to show promising results in fields such a
Genentech Inc. (NYSE: DNA) is set to report earnings after the close of trading today. The largest biotech in the U.S. is expected to post $0.86 EPS on $3.23...
[[ This is a content summary only. Visit my website for full links, other content, and more! ]]
The Nthrys Biotech Labs in Hyderabad has launched Nthrys bioinfo labs and they are offering "Minor and Major Project" training for B,sc, M.Sc, B.Tech, M.Tech bioinformatics , Biotechnology students and other interested candidates.Now the next batch admission going on and the project fees structure starting 3800 onwards .FOR MORE INFORMATION:The Nthrys biotech LabsHyderabadMobile : 9849854748Mail :
Out of the daily movers this last week, many of the top winners and losers were from news in many of the smaller biotech stocks. We prepared a list of the...
[[ This is a content summary only. Visit my website for full links, other content, and more! ]]
Comentario del IBEX 35: será por el comentario de Trichet, será por apatía, será por desconfianza, por lo que Ud. quiera, el caso es que aun no se han descontado todas las noticias negativas y a la mínima nos damos el batacazo. El selectivo finalizó, tras recortar un 0,76% en los 13.239 puntos, cotizó durante algunos momentos sobre los 13.400 puntos pero esta cota parece ir tomando fuerza c
El otro día comentamos sobre los nuevos botes inflables motorizados, una opción a tener en cuenta en materia de entretenimiento para este verano. Pero si deseas algo más sencillo y relajante, el nuevo Deluxe BioTech Spa, es lo que buscas.
Básicamente se trata de una pileta inflable con capacidad para cuatro adultos que te brindara un [...]
Baltimore — (TFN): The development of cutting-edge biologic drugs that are already improving – even saving – lives marks Osiris Therapeutics as a winner among biotech stocks. Their multi-purpose wonder-drug Prochymal is set to be the first FDA approved stem cell therapy.
Watch the video.
****Make sure you sign up for our FREE TFN [...]
A Today’s Financial News Research Report:
‘This Maryland-based biotechnology firm develops treatments for conditions as varied as Crohn’s disease, knee arthritis, tissue damage, life-threatening Graft-versus-host disease and acute radiation syndrome.’ – Laura Cadden
By Laura Cadden, TodaysFinancialNews.com
Today’s Financial News feed provides an indepe
Came across these interesting articles equating bio-technology with black magick and alchemy.One could say that the current food crisis resulting from biotechnology applied to mass production of foods as well as their commodification into bio-fuels is an act of black magick.Fulfilling the prediction made by Shulamith Firestone back in the seventies when she did her feminist critique of reproductiv
It's Biotech's Year: 'Eight Great' Business Plans Aim to Help People Live Longer and BetterA decade ago, when the Wharton Business Plan Competition (BPC) began, the Internet dominated discussions about entrepreneurship. That was before the bubble burst and many dot.coms were revealed to be, in the words of New Yorker writer John Cassidy, little more than dot.cons. These days, the new arena of inte
AMAG Pharmaceuticals (NASDAQ: AMAG) has been added to the Nasdaq Biotechnology Index (NASDAQ: NBI) beginning May 19, 2008. AMAG shares up $1.26 at $39.85. The...
[[ This is a content summary only. Visit my website for full links, other content, and more! ]]
In attempt to compete with more equal footing in the biotech market, Malaysian banks are offering finance loans to companies in this sector. It is hoped that a greater availability of finance loans will help new companies get started and help bring more money into Malaysia and more jobs. Although the biotech market is very [...]
Here are some of the top stories today that affecting key drug and biotech stocks: GlaxoSmithKline (NYSE: GSK) reorganized its corporate structure, increasing...
[[ This is a content summary only. Visit my website for full links, other content, and more! ]]
Cougar Biotechnology, Inc. (NASDAQ: CGRB) is up over 5% in afternoon trading on the announcement that they will present a company update and clinical trial...
[[ This is a content summary only. Visit my website for full links, other content, and more! ]]
Name: ravitejaQ: Sir i had completed my 2B.Sc bio-che.i wanna do M.Sc in IIT .and here my question is which subject should i take-(bioche Or biotech Or micro)to grow my future well in india.please inform immediatly as possible as i have to take coaching basing on ur suggestion.
There are lots of names moving in biotech and related fields today, and below are some of the top movers: Anika Therapeutics Inc. (NASDAQ: ANIK) moving up...
[[ This is a content summary only. Visit my website for full links, other content, and more! ]]
Generex Biotechnology Company (NASDAQ: GNBT), a drug delivery system and technology developer, has filed an offering by selling stockholders of up to...
[[ This is a content summary only. Visit my website for full links, other content, and more! ]]
Today almost feels like the "March of Biotech-inguins" because most of the movers were small companies you might otherwise miss. Here were the big movers:...
[[ This is a content summary only. Visit my website for full links, other content, and more! ]]
España, Madrid - Dos investigadores de la Escuela Técnica Superior de Ingenieros Agrónomos de la Universidad Politécnica de Madrid (UPM), Antonio Molina y Pablo Rodríguez acaban de crear la empresa ‘Plant Response Biotech’ para dar respuesta a las necesidades técnicas y científicas del sector agroalimentario, biotecnológico y bioenergético, según informó hoy la Universidad.
El equipo de ‘Plant [...]
Biogen Idec (NASDAQ: BIIB) is sliding marginally despite reported earnings today that showed a 23% increase in earnings riding on sales growth on Avonex and...
[[ This is a content summary only. Visit my website for full links, other content, and more! ]]
Amylin Pharmaceuticals (NASDAQ: AMLN) reported first quarter losses of $68.8 million, or $0.51 EPS, wider than the $49.4 million in the first quarter of 2007....
[[ This is a content summary only. Visit my website for full links, other content, and more! ]]
Promising career prospect in biotechnology industry in Malaysia may be hampered by low and uncompetitive salary package.
In late 2006, the International Herald Tribune reported some trend of Malaysian researchers migrating to the neighboring country Singapore for better environment and salary package.
The report, which also gave indication that as much as 60% of Singapore’s biotechnology researchers [...]
If you thought biotech news was getting quiet going into earnings season, think again. Acadia Pharmaceuticals Inc. (ACAD) presents Phase II data on...
[[ This is a content summary only. Visit my website for full links, other content, and more! ]]
Alkermes (NASDAQ: ALKS) and Johnson & Johnson Pharmaceutical Research and Developed today submitted paperwork seeking approval of their partnership drug,...
[[ This is a content summary only. Visit my website for full links, other content, and more! ]]
The $8.8 Billion cash buyout of Millennium Pharmaceuticals, Inc. (NASDAQ: MLNM) has created a situation worth monitoring today. It isn't just that this buyout...
[[ This is a content summary only. Visit my website for full links, other content, and more! ]]
Thursday after the close, we’ll get to see earnings out of Genentech (NASDAQ: DNA). The estimates from First Call are $0.82 EPS on $3.11 billion in revenues....
[[ This is a content summary only. Visit my website for full links, other content, and more! ]]
AspenBio Pharma (NASDAQ: APPY) entered into a definitive agreement with Novartis Animal Health for AspenBio’s recombinant single-chain bovine products for...
[[ This is a content summary only. Visit my website for full links, other content, and more! ]]
Panacea Biotech is predominantly recognized as the company that manufactures the polio vaccines in India. And recently the stock price saw a major spurt when the Union Budget announced that there would be increased allocation for polio and this company is to be one of the major beneficiaries. The future might be good but the same cannot be said about its Q3 performance.
The financial performance
CombinatoRx, Incorporated (NASDAQ: CRXX) up 8% to $3.45 on no recent developments. The 52-week range is $3.11 to $7.37. Yesterday, the company hit a 52-week...
[[ This is a content summary only. Visit my website for full links, other content, and more! ]]
Romania, which has until now been one of the most receptive European markets for genetically modified crops, is moving toward a reversal of its stance.
Romania's environment minister Attila Korodi said that he would ask a committee of experts to revaluate MON810, a gene-altered version of corn which is the only modified crop that has been approved for commercial planting in the European Union.
Korodi said that not enough studies had been done to gauge the effects of the corn on ecological systems in Romania, and that banning biotech crops could increase rural prosperity by allowing farmers to take advantage of a growing global demand for organic food.
Bentley Pharmaceuticals Inc. (NYSE: BNT) will be purchased by Teva Pharmaceutical Industries (NASDAQ: TEVA) for $360 million. Bentley shareholders will receive...
[[ This is a content summary only. Visit my website for full links, other content, and more! ]]
Israel's biotechnology sector is poised to attract more investment from venture capital funds over the course of the year, according to an Israel Venture Capital research paper.
Biotechs always have some news movers regardless of which direction the markets are headed. Here are some of the top movers in biotech today, although we would...
[[ This is a content summary only. Visit my website for full links, other content, and more! ]]
Many biotech stocks are enjoying large gains Monday, although some are on no real breaking news. Here is a look at some notable gainers: Amylin Pharmaceuticals...
[[ This is a content summary only. Visit my website for full links, other content, and more! ]]
It seems that Scientists will be serving up leaner beef, tastier cheddar and healthier ketchup. Just ask Rena Marie Pacella over at Popular Science.
According to her, if the biotech industry has it's way, ordering hamburger might soon sound something like this: "one charbroiled cloned-beef patty, with genetically modified cheese, lab-grown bacon and vitamin-C-fortified lettuce, on a protein-spiked bun." Basically, the burger of the future is delicious, nutritious and contains more engineering than a stealth bomber. With the Food and Drug Administration ruling in January that meat and milk from cloned cows, pigs, goats and their offspring is safe to eat, the only thing keeping the superburger off your dinner plate is time.
Hey, I'm a pro-science gal .. but in this case it seems to me tha
EPIX Pharmaceuticals, Inc. (EPIX) has seen shares essentially chopped in half today. Early this morning the company announced that it was discontinuing its...
[[ This is a content summary only. Visit my website for full links, other content, and more! ]]
Amicus Therapeutics (NASDAQ: FOLD) had a late afternoon surge, up 7% to $10.73. The 52 week range is $9.00 to $18.22. Baxter International (NYSE:...
[[ This is a content summary only. Visit my website for full links, other content, and more! ]]
Biotech’s are sliding along with all the others today. A look at the highlights and outliers: Amgen (NASDAQ: AMGN) and Wyeth (NYSE: WYE) announced that...
[[ This is a content summary only. Visit my website for full links, other content, and more! ]]
Genentech Inc. Chairman and Chief Executive Arthur Levinson collected compensation valued at $13.9 million in 2007 as the biotechnology giant watched its share prices fall amid slowing growth in sales of its cancer-fighting drugs.According to a proxy statement the company filed Wednesday with the Securities and Exchange Commission, Levinson received just under $1 million in [...]
Curis Inc. (NASDAQ: CRIS) shares down 18% after development partner Wyeth terminated their contract that focused on cancer treatment developments. Shares are...
[[ This is a content summary only. Visit my website for full links, other content, and more! ]]
Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX) may have just joined the ranks of a biotech zombie, even if it doesn't want to admit that. The company announced...
[[ This is a content summary only. Visit my website for full links, other content, and more! ]]
Comentario del IBEX 35: jornada de recorte para el IBEX que pese a todo sigue por encima de los 12.700 puntos, en un rango cada vez más estrecho del que saldrá en próximas sesiones. Hoy destacaron los fuertes recortes de Ferrovial (-4,2%) presionado por malas noticias y por la tendencia claramente bajista que parece empujar la cotización hacia los 37,90 €; Inditex (-3,7%); y Mapfre (-3,5%) presionada por la tendencia que la puede arrastrar nuevamente hacia los entornos de 2,50 - 2,60 €. Los ganadores han sido Iberia (+1,8%) que tras los fuertes recortes que acumula parece haber encontrado soporte en 2,20 €; Criteria (+1,7%) atentos al soporte en 4 €; y Grifols (+1,6%) que de momento conserva los 15 € aunque tiene resistencia clara en 17 €.Solaria: demasiada volatilidad. Hoy
Biotechnology is not all about white coated doctors hovering around petri-dishes and microscopes, finding out ways to make medicines and drugs better. The field of biotechnology is much more than that and holds immense career growth potential for a student.The "biological revolution' has led to a diversification in the field of biotechnology, encompassing an extensive choice of careers. Knowledge of biology, chemistry and other life sciences is necessary for a student to venture into this field.Biotech students can put their knowledge to use in agriculture, biology, medicine, genetics and education, livestock production, environmental protection, veterinary medicine, plant science, forensics, energy production and even in corporate laboratories.For students interested in biotechnology but without extensive expertise there are regulatory and authorizer positions which they can take up. A student can pursue a job in sales and marketing where intensive knowledge of biological processe
A study sponsored by the drug industry found that life science companies account for a diminutive, but growing part of the state’s economy. The study highlights the multiplier effect in the current pharmaceutical industry. For every job that it generates, an additional five jobs are created in another industry.A career in the biopharmaceutical field can be very lucrative as biotech organizations and drug corporations compensate generously. There is a wide selection of jobs that are available for the picking. A student could be a biostatistician, a chemist, or even a clinical programmer.Drug safety specialists, microbiologists, pathologists and toxicologists are some of the higher paying jobs in this field. A student can also apply for a job in the writing field as a technical or medical writer. The opportunities are endless and the best of the biopharm companies are hiring in numbers.The National Institute of Science Media under the helm of Joel Ball, the President, publishes career
Dan Pritch of Everyday Finance started digging around two biotech stocks, Clinical Data (CLDA) and HALOZYME THERAPEUTIC (HALO) after reading an article in BusinessWeek and found that they both have enormous potential.
RJ Kirk (billionaire biotech investor)owns 40% of Clinical Data. Kirk has shown a penchant for pursuing the right deals and having his companies taken out for premiums following their already impressive ascent.
They also have an antidepressant in Phase 3 and given the relatively weak pipelines of big pharma/biotech these da
We saw some interesting movement in a few names today, and thought we'd suggest some possible ways to trade them. Click through to see option trade ideas for:
Celgene (CELG)
Biogen (BIIB)
Microsoft (MSFT)
Apple (AAPL)
and be sure to let us know if you make bank from our free picks!
Genentech Inc. (NYSE:DNA) is set to report earnings after today's close. First Call has consensus...
[[ This is a content summary only. Visit my website for full links, other content, and more! ]]
How awesome would it be to have a clone? You might be tempted to think that I’d get a little more writing done if I had one, but if anything, I’d probably be writing less. Hell, I’m pretty hard-up for good conversation around these parts (what with neighbours obsessed with kicking and rapping, stealing medication from the Elderly and rooting their cats), so chances are I’d spend most of my time getting drunk and watching re-runs of King of the Hill with my clone. Sure, it’d be fun for the first few days, until the money and the beer ran out. I’m a thirsty motherfucker at the best of times, so I’d imagine my clone (Jon 2.0) would be doubly so. Sooner or later, we’d be bound to get into a fight about something and quite frankly, I’m so out of shape that I’m not sure if I could kick my own ass, should the need arise. One good nipple-cripple and I’d be a dead man. Cloning also raises another issue (and I’d imagine you saw this one coming a mile away)… if you ha
Metabasis Therapeutics (NASDAQ:MBRX) announced after the close today that its MB07133 has been...
[[ This is a content summary only. Visit my website for full links, other content, and more! ]]
Shares in Neurochem (NRMX) are down 30% today to a 52-week low of $3.70. According to The...
[[ This is a content summary only. Visit my website for full links, other content, and more! ]]
On today's STOP TRADING segment on CNBC, Jim Cramer discussed Freddie Mac (NYSE:FRE) and Fannie Mae...
[[ This is a content summary only. Visit my website for full links, other content, and more! ]]
Amgen Inc. (NASDAQ:AMGN) did what Wall Street thought it would in its after-the-bell conference...
[[ This is a content summary only. Visit my website for full links, other content, and more! ]]
Which is more important - Biotech or IT? Do we show it by our investments? Do we encourage one over the other by legislation? If there were two stories, two competing headlines, one for the new iPhone and one for the recent advance in diabetes research, which do you read? Which is more important for our future? Perhaps most people consider it sufficient to read about pharmaceuticals in the context of which celebutart (Lindsey Lohan, Paris Hilton, or Nichole Ritchie) has been arrested this week.I was intrigued by Guy Kawasaki's interview with Moira Gunn that he posted yesterday. I'm not sure I care for the title. I think that it might hurt her ability to be taken seriously but that is between Moira and Guy I suppose.My thoughts were piqued by one of the questions he asked? "Just how pervasive is biotech in our everyday lives?" I imagine that very few people realize how pervasive it is. Her answer was very enlightening. (the link above will take you there. I'm not s
Information provided by Oil Offshore Marine Online Library Series, and posted here, on Oil Offshore Marine Blog
Biotech Oil Nigeria Ltd
Any email or other communication (by telephone, fax or other form) originating from Biotech Oil Nigeria Ltd, www.biotechoilng.net, info@biotechoilng.net, recruitment@biotechoilng.net, or career@biotechoil.net MUST NOT be trusted, as Biotech Oil Nigeria are proven job scammers … Read More